GSK plc filed a Form 6-K on November 17, 2026, disclosing four transaction notifications for the month of November 2026 in which three persons discharging managerial responsibilities acquired notional or direct American Depositary Shares through dividend reinvestment in company plan accounts on November 13, 2026.

Key Highlights

  • Dr Hal Barron (Non-Executive Director) acquired 2,259.160 notional ADS in his GSK Executive Supplemental Savings Plan account and 72 ADS in his GSK 401(k) plan account, both at $50.4500 per ADS on November 13, 2026.
  • James Ford (SVP and Group General Counsel, Legal and Compliance) acquired 53.408 notional ADS in his GSK Executive Supplemental Savings Plan account at $50.4500 per ADS on November 13, 2026.
  • Maya Martinez-Davis (President, US) acquired 81.902 notional ADS in her GSK Executive Supplemental Savings Plan account at $50.4500 per ADS on November 13, 2026.
  • All transactions arose from the reinvestment of dividends within plan accounts, according to the filing.
  • Place of transaction for all four notifications was the New York Stock Exchange (XNYS), with the ADS carrying ISIN US37733W2044.
  • All notifications are described as initial notifications, filed on behalf of GSK plc (LEI: 5493000HZTVUYLO1D793).

GSK plc PDMR Dividend Reinvestment Details: November 13, 2026 Transactions

GSK plc (NYSE:GSK) submitted a Form 6-K to the U.S. Securities and Exchange Commission on November 17, 2026, containing four individual transaction notifications covering persons discharging managerial responsibilities (PDMRs). According to the filing, each transaction involved the acquisition of American Depositary Shares (ADS, ISIN: US37733W2044) through the reinvestment of dividends within GSK employee plan accounts, all executed on November 13, 2026, at a price of $50.4500 per ADS.

The filing reports that Dr Hal Barron, Non-Executive Director, was the subject of two separate notifications. The first covered the acquisition of 2,259.160 notional ADS within his GSK Executive Supplemental Savings Plan account. The second covered the acquisition of 72 ADS within his GSK 401(k) plan account. Both transactions occurred at $50.4500 per ADS. James Ford, SVP and Group General Counsel, Legal and Compliance, acquired 53.408 notional ADS in his Executive Supplemental Savings Plan account at the same price. Maya Martinez-Davis, President, US, acquired 81.902 notional ADS in her Executive Supplemental Savings Plan account, also at $50.4500.

The filing designates all four notifications as initial notifications. Each transaction is described as a single transaction with no aggregated volume reported separately. The place of transaction for all four is listed as the New York Stock Exchange (XNYS). The report was signed by Victoria Whyte as Authorised Signatory on behalf of GSK plc.

What Was Disclosed

GSK plc's November 2026 Form 6-K disclosed four PDMR transaction notifications for dividend reinvestment acquisitions of ADS on November 13, 2026, involving Dr Hal Barron, James Ford, and Maya Martinez-Davis, at $50.4500 per ADS across GSK plan accounts.